Retatrutide, from Soma Pharmaceuticals , is gaining increasing attention as a potential therapy for weight regulation. This innovative compound combines the mechanism of a GLP-1 receptor agonist and a GIP receptor activator , intended to effectively promote metabolic improvements but also address